carbapenems has been researched along with gentamicin in 46 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.87) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 4 (8.70) | 29.6817 |
| 2010's | 21 (45.65) | 24.3611 |
| 2020's | 10 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Lahnborg, G; Nord, CE | 2 |
| Bergholm, AM; Dornbusch, K | 1 |
| Andrews, JM; Ashby, JP; Wise, R | 1 |
| Livermore, DM; Said, AA | 1 |
| Dornbusch, K; Henning, C; Lindén, E | 1 |
| Chin, NX; Neu, HC | 1 |
| Edwards, JR; Nairn, K; Shepherd, GL | 1 |
| Hostacká, A | 1 |
| Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N | 1 |
| Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
| Jones, RN | 1 |
| Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A | 1 |
| Biedenbach, DJ; Huynh, HK; Jones, RN | 1 |
| Adler, A; Benenson, S; Block, C; Carmeli, Y; Moses, AE; Navon-Venezia, S; Strahilevitz, J | 1 |
| Aslamkhan, AG; Bailey, W; Clouse, H; Figueroa, DJ; Gerhold, DL; Holder, D; Jin, H; Muniappa, N; Ozer, JS; Seng, J; Shi, S; Shughrue, P; Sistare, FD; Su, M; Thudium, D; Troth, SP; Villarreal, S; Yu, Y | 1 |
| Bailey, WJ; Chibout, SD; Clouse, HK; Cordier, A; Dieterle, F; Erdos, Z; Forest, T; Gerhold, DL; Glaab, WE; Grenet, O; Holder, D; Jin, H; Legay, F; Mahl, A; Maurer, G; Muniappa, N; Ozer, JS; Perentes, E; Reynolds, S; Roth, DR; Sina, JF; Sistare, FD; Skopek, TR; Staedtler, F; Thudium, DT; Topper, MJ; Troth, S; Verdes, P; Vlasakova, K; Vonderscher, J; Wahl, D; Yu, Y | 1 |
| Benyamini, N; Fineman, R; Finkelstein, R; Oren, I; Rowe, JM; Sprecher, H; Zuckerman, T | 1 |
| Bogaerts, P; Bouchahrouf, W; de Castro, RR; Denis, O; Deplano, A; Glupczynski, Y; Tsobo, C | 1 |
| Borer, A; Codish, S; Eskira, S; Peled, N; Polachek, H; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolykov, R; Trabelsi, Y; Yousef, B | 1 |
| Casini, B; Costanzo, S; Leonetti, P; Leonildi, A; Malacarne, P; Menichetti, F; Sbrana, F; Tascini, C; Viaggi, B | 1 |
| Chan, WW; Peirano, G; Pitout, JD; Smyth, DJ | 1 |
| Douthwaite, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; Hopkins, KL; Ovejero, CM; Prasad, KN; Shukla, S; Woodford, N | 1 |
| Chen, L; Clancy, CJ; Hao, B; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK | 1 |
| Gonzalez-Padilla, M; López-Cerero, L; Natera, C; Pascual, A; Pontes-Moreno, A; Rivera-Espinar, F; Rivero, A; Rodríguez, M; Rodríguez-Baño, J; Rodríguez-López, F; Salcedo, I; Torre-Cisneros, J | 1 |
| Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| Chen, Y; Gao, W; Li, X; Ouyang, W; Wei, J; Wen, Z; Xue, H | 1 |
| Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Fortunato, S; Lambelet, P; Leonildi, A; Menichetti, F; Simonetti, F; Stefanelli, A; Tascini, C; Vettori, C | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Ambretti, S; Bartoletti, M; Bartoloni, A; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Lewis, RE; Losito, AR; Marchese, A; Raffaelli, F; Rossolini, GM; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| Abu Sin, M; Claus, H; Eckmanns, T; Feig, M; Koppe, U; Kroll, LE; Noll, I; Schneider, M; von Laer, A | 1 |
| Jin, X; Jin, Y; Wang, K; Wang, Y; Yu, J; Zhang, Q | 1 |
| Burgess, DS; Clark, JA; Kulengowski, B | 1 |
| Ali, HB; Asuman, B; Kubra, HU; Sarah, AF; Sreylis, N; Yeliz, TC | 1 |
| Almeida Amaral, F; Boff, D; César Moreira Brito, J; Cristina Sampaio de Assis, D; Elena de Lima, M; Gustavo Lima, W; Magalhães Resende, J; Maria Souza-Fagundes, E; Nascimento Cardoso, V; Odília Antunes Fernandes, S | 1 |
| Ambretti, S; Antonelli, A; Bartoletti, M; Bassetti, M; Bussini, L; Cavallo, R; Coppi, M; Corcione, S; De Rosa, FG; Dettori, S; Gaibani, P; Giacobbe, DR; Giani, T; Giannella, M; Lewis, R; Marchese, A; Marconi, L; Pascale, R; Rossolini, GM; Shbaklo, N; Viale, P | 1 |
| Abouelhassan, Y; Bourdages, G; Gutierrez, RL; Kufel, WD; Nicolau, DP; Perwez, T; Steele, JM | 1 |
| Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Archer, E; Botes, M; Bröcker, L; Carstens, A; Feil, EJ; Kasprzyk-Hordern, B; Mageiros, L; Meric, G; Mourkas, E; Nel, D; Pascoe, B; Sheppard, SK; Smith, K; Tucker, K; Wolfaardt, G | 1 |
| Huang, Y; Liu, H; Lu, W; Peng, J; Qin, G; Wu, D; Xiao, J | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
1 review(s) available for carbapenems and gentamicin
| Article | Year |
|---|---|
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
1 trial(s) available for carbapenems and gentamicin
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Colistin; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Groin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pharynx; Rectum; Urine | 2012 |
44 other study(ies) available for carbapenems and gentamicin
| Article | Year |
|---|---|
Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats.
Topics: Abdomen; Animals; Bacterial Infections; Carbapenems; Disease Models, Animal; Gentamicins; Intestines; Male; Metronidazole; Rats; Rats, Sprague-Dawley; Thienamycins | 1992 |
Synergy and cumulated killing effect of the penems FCE 22101 and FCE 25199 in combination with gentamicin against bacteria isolated from septicaemia.
Topics: Animals; Bacteria; Carbapenems; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella; Microbial Sensitivity Tests; Rabbits; Sepsis; Staphylococcus aureus; Streptococcus sanguis | 1991 |
The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Topics: Carbapenems; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Gentamicins; Kinetics; Meropenem; Methicillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 1989 |
In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Interactions; Gentamicins; Gram-Negative Bacteria; Lactams; Microbial Sensitivity Tests; Tobramycin | 1989 |
In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Synergism; Endocarditis, Bacterial; Gentamicins; Humans; Lactams; Microbial Sensitivity Tests; Netilmicin; Streptococcus; Time Factors | 1989 |
Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Gentamicins; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Time Factors | 1989 |
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Topics: Carbapenems; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Carbapenemase-producing Pseudomonas aeruginosa in UK.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom | 1998 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Evaluation; Drug Resistance; Drug Synergism; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Phenotype | 2001 |
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin | 2006 |
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside.
Topics: Aminoglycosides; beta-Lactam Resistance; beta-Lactams; Carbapenems; Doripenem; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2006 |
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome | 2009 |
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.
Topics: Albuminuria; Animals; Biomarkers, Pharmacological; Carbapenems; Cisplatin; Gentamicins; Histocytochemistry; Iridoid Glycosides; Iridoids; Kidney Diseases; Kidney Tubules; Logistic Models; Neuropeptides; Rats; ROC Curve; Trefoil Factor-3 | 2010 |
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.
Topics: Animals; Biomarkers, Pharmacological; Blood Urea Nitrogen; Carbapenems; Creatinine; Cystatin C; Drug-Related Side Effects and Adverse Reactions; Female; Gentamicins; Kidney; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; ROC Curve | 2010 |
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pilot Projects; Stem Cell Transplantation | 2011 |
Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.
Topics: Adult; Aztreonam; beta-Lactamases; Carbapenems; Colistin; Female; Gentamicins; Greece; Humans; Klebsiella pneumoniae; Medical Tourism; Minocycline; Plasmids; Tigecycline | 2011 |
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Female; Gentamicins; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome | 2013 |
The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece.
Topics: Adhesins, Bacterial; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Fimbriae Proteins; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Travel; Virulence Factors | 2013 |
Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.
Topics: Amikacin; Aminoglycosides; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; India; Methyltransferases; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; United Kingdom | 2013 |
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
Topics: Algorithms; Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Genotype; Gentamicins; Glycine; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Porins | 2014 |
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
Topics: Anti-Bacterial Agents; Carbapenems; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Epidemiologic Studies; Escherichia coli; Female; Gentamicins; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome | 2016 |
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Female; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Rectum | 2017 |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Topics: Aged; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Propensity Score; Tertiary Care Centers; Tigecycline; Treatment Outcome | 2018 |
Carbapenem non-susceptibility of
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Germany; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2019 |
In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2020 |
Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 2021 |
Pegylated LyeTx I-b peptide is effective against carbapenem-resistant Acinetobacter baumannii in an in vivo model of pneumonia and shows reduced toxicity.
Topics: Acinetobacter baumannii; Animals; Antimicrobial Cationic Peptides; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; HEK293 Cells; Humans; Mice; Microbial Sensitivity Tests; Peptide Fragments; Peptides; Pneumonia; Polyethylene Glycols; Receptors for Activated C Kinase | 2021 |
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales.
Topics: Agar; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Fosfomycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Tigecycline | 2022 |
Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gentamicins; Humans; Meningitis; Microbial Sensitivity Tests; Middle Aged | 2022 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
Spatiotemporal Investigation of Antibiotic Resistance in the Urban Water Cycle Influenced by Environmental and Anthropogenic Activity.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthropogenic Effects; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Gentamicins; Sewage; Sulfamethoxazole; Wastewater; Water Cycle | 2022 |
The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin | 2023 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |